DatasetName,CDK17_S(116) CDK17_S(146) CDK17_S(182),CDK17_M(127) CDK17_S(105) CDK17_S(112) CDK17_S(122) CDK17_S(127) CDK17_S(129) CDK17_S(137) CDK17_S(138) CDK17_S(165) CDK17_S(173) CDK17_S(177) CDK17_S(180) CDK17_S(227) CDK17_S(3) CDK17_S(444) CDK17_S(69) CDK17_S(75) CDK17_S(84) CDK17_S(9) CDK17_S(92) CDK17_S(93) CDK17_T(202) CDK17_Y(203)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.6341053551143427,0.4922058089090382
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.6353512973073769,0.49023093442539983
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.5037195774357748
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.6529869002956278,0.49163952300490776
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.6047154239577349,0.49640599331798824
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,0.4917658530715069
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,,0.4658189776265455
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,0.6692571300843979,0.4962439692141
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.6529730580049692,0.49160733426940356
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,0.4920187901655844
RB2022_5_PreEndurance,,0.48816151185826845
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.48205890335323015
WZ2023_Pu_010_30min,,0.5006775819786131
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.6654363289964116,0.48679632017269764
RB2022_8_RecoveryEndurance,,0.49156389779567156
KBE2022_Log2_Ex_14_U,,0.47381687842478964
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.6492549213750091,0.4939280637376914
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,0.6471863179793197,0.48901731325459447
RB2022_5_PreSprint,,0.48552479077116395
PG2020_Intensity 8h_C,0.5770326983235312,
AH2018_SILAC_MR_2_N,0.6645052435017372,0.48176184473583566
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.625547194629655,0.49399259725069866
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.4933924374486682
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,0.4908497274434196
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,0.4836451698220525
GF2025_P6_Sph,0.6880113538563215,0.5076184432465471
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.5067217200926202
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,0.4915704023067579
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,0.4740981799438348
WZ2023_Pu_005_10min,,0.5065396828568437
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,0.4691643882361335
WZ2023_Pu_025_30min,,0.5033501238171424
AH2018_SILAC_MR_2_X,0.6813907241695043,0.4798664764070152
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.647368023094573,0.48391278716801944
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,0.49400764168868067
EJN2021_3_Rest_Basal,,0.4749629685836536
CR2017_Ratio Replicate 1.3,0.6147964450509341,0.5027486274599048
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.6353079221644037,0.4873878416581889
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.6424144824606667,0.4880102461005271
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.6352664839141392,0.49817605701323414
AH2018_LFQ_1_C,0.6355421997912631,0.47247106868030037
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,0.47126567013162834
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,0.4991075610496024
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,0.6151959943053448,0.48549457486300857
AH2018_SILAC_2_X,0.63678740101603,0.48589912875891594
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,0.4850868196114616
FSO2013_Ratio H/L normalized Rep2,0.6097562661846947,0.49575361358707626
WZ2023_Pu_005_20min,,0.49997310566332887
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.6724466314994219,0.4753047318302179
CW2012_10 µM Gef/control Experiment 2 Replicate B,0.649759631074847,0.4809273697641378
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.6432705076002435,0.47927637211686475
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,0.4847368679192834
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,,0.49142771112016936
PG2020_Intensity Mock_10h_D,0.5751511824752077,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,0.48610755539694184
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,0.4837396392206118
EP2017_Mitotic R#2 normalized log2 ratio,,0.4771839942081466
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,0.4883169826990896
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5852931736022198,0.5019590983317354
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.5032697439515817
KBE2022_Log2_Ex_8_T,,0.47177762419972674
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,0.47673744652605665
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.6973205012983591,0.4874839927156135
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.6205272615499582,0.49601420647708633
HH2022_Reporter intensity 8,,0.4848627335991945
ZQ2022_N2,0.5805718951139444,0.48585396721642615
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,0.49348236823943564
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.7015050493908349,0.4847980652022805
EJN2021_5_Rest_Basal,,0.4744300568493117
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,0.4649872871330635
JAW2011_Ratio H/L LS2_1,,0.49222749958841766
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.6391674736502212,0.48943037629556524
YA2020_Reporter_intensity_Normal_No.1,0.6136589174784027,0.4924210732283246
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,0.49014158310744305
RB2022_1_PostEndurance,,0.4936908396530975
CR2017_Ratio Replicate 3,0.6599055483550026,0.4951525845637088
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.6723097306554336,0.4888762524841191
HS2024_8_I_T3,,
CF2017_EOC 3,,0.4812468412325
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,0.4881556549119777
WZ2023_Pu_010_20min,,0.5031016181741506
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,,0.4887442146057816
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,0.47867384587948497
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.6409059052113149,0.4710574199665448
FSO2013_Ratio H/M normalized Rep2,0.6504527298206205,0.4925936962855475
RAM2015_Log2 A,,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.49000273753881884
KS2014_Intensity E15_2,,0.48162647014497606
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5810181397314499,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.6359306831981816,0.48766579846695474
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,0.47417814651783846
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.6549380825477261,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,0.4938877418517204
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.4814520676897085
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,,0.4755461752603166
CW2012_10 µM Gef/control Experiment 1 Replicate A,0.6344317959020196,0.4786683161807345
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.48780205283188477
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,0.48902404249705456
AH2018_SILAC_IT_3_X,0.6499357483144342,0.498958513385849
JAW2011_Ratio H/L,,0.49233102908093906
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,0.6699535133875286,0.5022451602726025
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,0.48692414103590503
SR2019_HCC1954_Biol_repl_2,,0.47721646446158855
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.6639324811397548,
DL2023_control-1,,
AR2021_ALG 10 μM,,0.48240993283404365
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.6493542242947079,0.5001945856484574
EJN2021_4_Rest_Ins,,0.4820399677619961
RN2012_H05,,0.4850268649971806
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5761111507625131,0.48276388739328985
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,0.48757829385985135
EJN2021_1_Rest_Ins,,0.4837187679664999
HH2022_Reporter intensity 3,,0.48525379293013027
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,0.48805190083717187
AH2018_SILAC_IT_1_C,0.6300708268813633,0.4936696995928247
JW2021_After_3,,
GF2025_P8_Sph,0.6964215629918201,0.5090585587181188
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,0.4876167650098902
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.6413270668494059,0.4876103879008003
CK2022_11 200-1,,0.48697513935794984
CK2022_12 200-1,,0.4866017916421629
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,0.48548805858409855
WZ2023_Su_010_20min,,0.49164868841322296
AH2018_TMTMS2_2_N,0.6582720686870768,0.4974564918963097
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,,0.46538748129179114
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.48707781041756565
AH2018_TMTMS3_Pool,0.7172069108902205,0.48544474474075405
KS2014_Intensity N4,,0.48838002874906294
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,0.49403984393247663
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.481875515515498
CK2022_14 200-1,,0.4972074345914762
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,0.49610028702846837
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.7336939242035357,0.49289006241482547
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,0.4832949019884464
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,0.6566446000402916,0.49682002453345814
GF2025_P1_Sph,0.6979936678041225,0.5158934055754478
EJN2021_5_Ex_Basal,,0.4823404792909722
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,0.5052862516492179
CF2017_EOC 1,,0.4805934730352719
CK2022_3 200-1,,0.49214270312993813
AH2018_LFQ_IT_3_C,0.6361773646307877,0.4857790251789162
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,0.4882525549421101
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,0.5773924681043997,0.4832518009861762
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,0.49532845149027577
CK2022_4 200-1,,0.49103473148942295
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,,0.4808914592914905
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,0.4738403109358104
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5903952400449711,0.49609253632429273
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,0.47829826930236796
GF2025_P7_Adh,0.5653455290019288,0.486813033043331
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.4978486917106618
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.47871836453999345
CK2022_16 16-1,,
FS2019_db/db3,,0.47963997199754654
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,0.49921712262003304
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,0.46544973014186575
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.6366313068424777,0.48587100293798396
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.7028959424407898,0.4843774013867699
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,0.6358434480645481,0.49665380653839736
KBE2022_Log2_Ex_40_U,,0.4746545254774546
AH2018_LFQ_M_1_N,0.6662997063530903,0.4881983386461108
KBE2022_Log2_Ex_27_U,,0.47792656908567105
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.6415402570557432,0.4735514878729511
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,0.48887195773315717
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,0.4742311804229009
YA2020_Reporter_intensity_Normal_No.4,0.6148668598732868,0.49414075115390116
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5652616341300621,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,0.47869320484576866
LG2023_Control-1_intensity,,0.4837927840920045
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,0.47482279408580547
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,0.5997532278796212,0.4824117899147077
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.6539640223421906,0.4953788202131847
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.6483789761578723,0.48297138621080765
HH2022_Reporter intensity 6,,0.48851000004368156
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.700741011459613,0.4939630732651646
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.6585664980694492,0.49732550473579457
GF2025_P3_Adh,0.545529195295428,0.47201290877515495
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.6584972061849779,0.49731277458050194
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.6382179463940846,0.4934928700454488
KBE2022_Log2_Ex_19_U,,0.47110504347136684
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,0.4799796269001715
YA2020_Reporter_intensity_Cancer_No.1,0.6194061654249673,0.49597146189919783
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.6682864765557568,0.5016993437535591
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,0.49134825983262437
RB2022_7_RecoverySprint,,0.49323061181341055
YA2020_Reporter_intensity_Normal_No.3,0.6167375017700255,0.4931681522571711
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.6362789751925287,0.4825947626836646
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,0.49060675691412997
HH2022_Reporter intensity 1,,0.4852875015473044
HH2022_Reporter intensity 2,,0.4851462611580879
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,0.48168851318885486
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.6172095521477623,0.49439677872643845
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,0.48486853316717116
SR2019_LM2_Biol_repl_3,,0.48407129261966864
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,,0.48464478843908215
CW2012_10 µM Erl/control Experiment 2 Replicate A,0.6569529112389704,0.4814028140884664
FSO2013_Ratio H/M normalized Rep3,0.6215239545331509,0.4757270264369523
AR2021_KD 72h,,0.4913455447802598
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,0.4630543229547121
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.7098230713055708,0.48665331377304594
KBE2022_Log2_Ex_9_U,,0.463366406614042
AH2018_SILAC_M_3_N,0.6399164973366885,0.4896778442529312
KBE2022_Log2_Ex_13_T,,0.47064875805370454
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,,0.4915631999495908
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.6363279248895748,0.48781871812566296
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.6521596339363176,0.5005506327705116
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,0.4866484821946429
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,0.481556357690825
TM2022_S2.12h.B,,
RN2012_L15,,0.47805485604451253
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.554733663092567,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,0.46940027679012947
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.4833779223003002
RB2022_1_PreSprint,,0.485704909150218
HS2024_4_I_N1,,
CK2022_7 200-1,,0.487030154605361
CK2022_5 200-1,,0.48760067622799336
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.6100204028837127,0.49607602988384875
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.6916401963504745,0.48639393968076505
AH2018_SILAC_MR_1_X,0.6596916386989772,0.4869916470414846
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,0.46904801142861496
AH2018_SILAC_3_C,0.6363680963389249,0.4878265037715739
EJN2021_5_Rest_Ins,,0.48360724222804385
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.6505531025916304,0.498948563115195
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,0.4809439703740267
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.6603342723203043,0.48727709749450454
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,0.59493320940988,0.49025456287063685
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,,0.4616154329724665
AH2018_SILAC_IT_2_N,0.6456694210262824,0.49962094998028184
AH2018_SILAC_IT_1_X,0.6453762534217785,0.4944251511799219
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.6711659171726287,0.5056182456268569
WZ2023_Pe_025_20min,,0.4915827566653764
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.6524631173910856,0.4786970877662795
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.648904397300203,0.49377871719594457
RN2012_H06,,0.4895841641434677
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,,0.4986806834552671
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.6796910262222305,0.5011858675018279
WZ2023_Su_025_10min,,0.5027719304942815
AH2018_LFQ_IT_4_X,0.6353245263445039,0.48737657521144784
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,0.49941950925112605
CW2012_10 µM Gef/control Experiment 1 Replicate B,0.7008439064556858,0.4791264123234885
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,0.5878868762023143,0.47697462943055335
RB2022_1_PreEndurance,,0.48458713342050036
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,0.4904501081513116
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,0.4950218580932169
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,0.48558047754840195
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5940619741550331,
LY2019_P7+,0.5919191742013564,0.4818958627642698
EP2017_Untreated R#1 normalized log2 ratio,,0.5033574892314077
RN2012_L10,,0.4857134661011283
PG2020_Intensity 4h_C,,
EP2017_Mitotic R#3 normalized log2 ratio,,0.485416736929385
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,0.4664196030657158
RB2022_8_PostStrength,,0.4932894757812899
AH2018_SILAC_IT_2_X,0.6457187522479697,0.49840704480184395
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,0.4760201684288634
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.597491988084065,0.4818190272535326
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.4977670142009971
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.4855436057048126
GF2025_P9_Sph,0.669692546120079,0.48053822866864887
CK2022_6 200-1,,0.4880787109710632
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.6988700938245449,0.4853051392637661
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,0.48065371412154884
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,0.48329399667947553
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,,0.48308828149807903
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,0.49192117216047554
CK2022_8 200-1,,0.486766322314557
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5972305759581088,0.4889093297749401
RB2022_7_PostEndurance,,0.4903870708080688
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.49528908756230294
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.6363699566310613,0.4858170865263726
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,,0.4609825275136706
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,0.6159929232735737,0.4874757146590321
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,0.6420918467857565,0.49522041683284324
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,0.4815304456190189
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.6711863135743039,0.4885698943292685
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.4902621583493208
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,0.48562429181132105
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,0.47412760442590696
EP2017_Untreated R#3 log2 ratio,,0.48228803316633617
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5717248362169468,0.4810911696823918
HS2024_8_PD_T2,,
FS2019_Ctr2,,0.4814537989614607
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,0.4775168430744427
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5985754391735423,0.49843612664483133
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5979829212830213,0.4995312002944543
YA2020_Reporter_intensity_Normal_No.2,0.6208613786699594,0.4957808602106944
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,0.48439416522666096
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.6600414264780211,0.4836502883530307
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,0.4716814971697097
CK2022_2 16-1,,
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,0.484102983836407
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,,0.4949532636401437
AH2018_LFQ_4_N,0.6648056232775151,
CR2017_Ratio Replicate 1.2,0.6186403998404234,0.5014143208765188
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,0.4880173905734575
AH2018_SILAC_M_1_X,0.6384309208514073,0.4766865978597815
RB2022_7_PreEndurance,,0.49465299284714126
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.6169154002543947,0.48395289385081086
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.6182721928529894,0.48170966218749867
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,0.47876202514707406
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.7174596916404384,0.48318099725013136
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,0.4725350186961475
KS2014_Intensity C5,,0.48372581820230154
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,0.5943790110709063,0.49482407156244174
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5589702730630935,0.4729376171569517
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,0.47747847125441983
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,0.48357587714698874
AH2018_LFQ_M_4_N,0.6714830335988404,0.47762283855742654
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5914597354967649,
AH2018_LFQ_2_X,0.676868717897262,0.47670393964054264
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,0.4833815951666516
GF2025_P3_Sph,0.5876563757024534,0.48661518890735067
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.6353408168621385,0.4902556734091177
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.48429192948400357
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.6468784887458076,0.4996296004606724
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.69889112998848,0.48518653600696793
ZQ2022_N1,0.6298587900853588,0.48314451264391023
LY2019_P6-,0.6258594384827082,0.48905442236345564
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.47325741017398
AH2018_LFQ_3_N,0.6823605349525859,0.4871463868187122
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,,0.47541856310947805
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,0.48374734190021784
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,0.4878075723325204
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,0.4852643132095026
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,0.48914705461866226
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,,0.494261939460708
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.6455578510199049,0.485917586182249
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,0.48646796199183834
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.6312973098995115,0.49554118260986796
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,0.49465502369542846
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,0.494383459350036
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,0.4857383329592058
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.48340467135201903
EP2017_Pervanadate R#3 log2 ratio,,0.49370253752391596
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.665390116083922,0.48870178203986764
AH2018_LFQ_M_4_C,0.6711777197782398,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.4876858618745309
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,0.4750140959790708
LY2019_P3-,0.6164163796614432,0.4816048379039772
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,0.48157773694583556
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,0.5010252587622692
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,0.483871348910532
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,0.4805552772385793
WZ2023_Pu_025_20min,,0.49893214537661895
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,0.48751892029225724
GF2025_P10_Adh,0.5765824019395239,0.47251994579313045
RB2022_1_RecoveryStrength,,0.48640599112025956
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.6518806759403395,0.49859721639512783
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.7153341086139365,0.48694995107508615
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.6389166017099377,0.49205691753645353
LY2019_P8+,0.5839404431756713,0.4869512808603481
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.4857977806627216
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.6624679905183678,0.4629218341876008
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,0.48528574867900764
KBE2022_Log2_Ex_28_U,,0.4698083793521803
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.49350711087603505
LY2019_P2-,0.6002670445231358,0.48172034610614267
AH2018_LFQ_IT_1_X,0.637561415303233,0.4745797605319569
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,0.47546912350389864
WZ2023_Pe_005_20min,,0.4945878177288699
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,0.48556981907757907
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,0.640838003512176,0.49646656450364823
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,0.4885489467689466
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.49104605477132024
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,0.4667446692554577
AH2018_TMTMS3_3_N,0.7084444866735833,0.484858600645068
SR2019_HCC1419_Biol_repl_2,,0.48527392393394875
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.6219560616695617,0.4776039029491908
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,0.47551626657015467
KBE2022_Log2_Ex_36_T,,0.46405663758573484
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,,0.49305673963060903
KS2014_Intensity C2,,0.47838134391853904
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,0.47182372783637033
CK2022_9 200-1,,0.48547957869139857
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.485365434192834
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.5703639687172252,0.48847475434716553
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.6464211269252784,0.48057637226129835
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,0.4861823409866361
ZQ2022_C3,0.6513396117304079,0.48652489698362383
EJN2021_3_Rest_Ins,,0.4835240604915594
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,0.47230803295083296
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,0.5027427200892016
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,0.4989268465266715
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,,0.4874641388747849
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.58400144186456,0.4886538819217532
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.6180672820854921,0.48147777326664726
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.6866986960393779,0.48820198227533323
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.4901826394896768
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,,0.484558321883638
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,0.48504635236962207
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,0.49874174045133873
KBE2022_Log2_Ex_29_U,,0.4618858483342739
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.6836499468327949,0.4825175234750029
AH2018_LFQ_IT_4_N,0.639168225344378,0.4894090409823956
CK2022_15 200-1,,0.49803550954278814
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,0.47156168458020686
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.6078037733446002,0.4867765560793595
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.49260946903806946
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,0.4917772740671082
RN2012_H01,,0.49706083201729706
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.4829282296714212
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,0.48010509349149405
EP2017_Pervanadate R#1 normalized log2 ratio,,0.4948040738291094
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.6232316061427544,0.49328561888055966
KBE2022_Log2_Ex_44_U,,0.46723824296608746
WZ2023_Pe_010_20min,,0.49537885268619386
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,,0.48532328277401005
FSO2013_Ratio H/M normalized Rep3___1,0.6217445772796193,0.47611216867930395
AH2018_SILAC_M_3_C,0.637078905974446,0.4881158817621954
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,0.4843693118031349
AH2018_SILAC_M_2_C,0.6373211786424481,0.48619410602924595
AH2018_SILAC_M_2_X,0.6348156638908476,0.48545325331036127
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,0.47367601082976074
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,0.4929456485764096
PG2020_Intensity 6h_C,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,0.4844428263235889
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.6884838485542045,0.48820162850753535
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.6565996728037549,0.4961861762114661
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,0.6574874355886182,0.4937837070488689
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5567947296449917,0.471240821014029
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.6206169722615716,0.47495717813153765
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.4871912833979002
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,0.4744362830316576
EJN2021_2_Ex_Basal,,0.48154262550983695
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.4890864048945009
AR2021_L41 10 μM,,0.4780116910758806
CF2017_EOC 2,,0.47638106325714036
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.6408629447790452,0.4710589932883828
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,0.4885920428909254
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,0.500294982545949
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,0.4852075146795859
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,0.48568684528974304
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.6510909570458976,0.49731716679573046
AR2021_L41 1 μM,,0.4772140707053038
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.6665235913164546,0.4976024774620481
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,0.487668448871165
ZX2022_Control Replicate 3,,0.5014893532513754
KS2014_Intensity C4,,0.4862687523543515
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,0.4627028070004059
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,0.48495197326084066
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.6595585454144577,0.48757117267611905
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.623512157190281,0.49573487971374947
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,0.4866756256639377
AH2018_SILAC_IT_3_C,0.6435612887242831,0.474421372627365
WZ2023_Pu_025_10min,,0.5052219177812347
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.6332273531119297,0.492034085220804
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,0.4838452118901374
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,,0.4955030490054659
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.641197312193998,0.4875767602901295
KS2014_Intensity C6,,0.4854726850384581
ZQ2022_N3,0.6024649193091016,0.48641040348651426
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.5009389472849652
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.6298387141090313,0.47957141351166
CK2022_5 40-1,,
AH2018_LFQ_3_X,0.6770366033824611,0.4771451622254069
UK2020_UA_3,,
LY2019_P7-,0.5638690926196257,0.4819073004208541
GF2025_P5_Adh,0.6256127285222656,0.5010203331856108
RB2022_1_PostStrength,,0.4897681149356412
JAW2011_Ratio H/L LS1b,,0.4878075723325204
FSO2013_Ratio H/L normalized Rep3___1,0.5954725721491431,0.4905800221059019
SR2019_HCC1954_Biol_repl_3,,0.48094129856019735
CR2017_Ratio Replicate 2.2,0.6355296333548875,0.4800332157036947
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,0.6290163754931544,0.4874673910774341
CR2017_Ratio Replicate 2.1,,0.4814631621305239
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.6724910356550229,0.48606251004232803
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,0.4804554152852766
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,0.4926646518480672
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.6516504077775852,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.6833201338822216,0.4820611566672349
YA2020_Reporter_intensity_Cancer_No.4,0.619766466902234,0.4959230189666568
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.6507504995504351,0.4952369913384857
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,0.46738493507265055
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,0.47450266826793347
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,0.48642139056829575
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,0.47370009532614377
AH2018_TMTMS2_1_X,0.6618473905513377,0.49736611338343295
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,0.48385207684418857
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,0.4896243194367058
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,0.48031066827366986
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.4899227257707197
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.6375623487420539,0.4745718991326636
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.726489565288721,0.48812694176291693
CF2017_FTE 14,,0.49044636343319975
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,0.48172426359546494
PG2020_Intensity 6h_A,0.5513973695040555,
SR2019_HCC1419_Biol_repl_3,,0.48536945623490235
KBE2022_Log2_Ex_14_T,,0.473350511904438
EP2017_Untreated R#2 normalized log2 ratio,,0.4854805954744451
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5992206988468773,0.4846819766854613
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,0.4955963255468115
AS2011_Ratio H/L Normalized RNAi_2_1,,
